Advanced search
Publication Cover
Journal of Addictive Diseases Volume 26, 2007 - Issue 1
Submit an article Journal homepage
193
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Correlation Between High Methadone Doses and Methadone Serum Levels in Methadone Maintenance Treatment (MMT) Patients

Miriam Adelson MD Clinic for Drug Abuse, Treatment & Research, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel; Clinic for Drug Abuse, Treatment & Research, Las Vegas, Nevada, USA; Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA
,
Einat Peles PhD Clinic for Drug Abuse, Treatment & Research, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
,
Gershon Bodner MD Internal Medicine E, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
&
Mary Jeanne Kreek MD Internal Medicine E, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
Pages 15-26 | Published online: 25 Sep 2008

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Elad Malik, Lihi Rozner, Miriam Adelson, Shaul Schreiber & Einat Peles. (2021) The Relation between Changes in Vitamin D and Vitamin B12 Levels, Body Mass Index and Outcome in Methadone Maintenance Treatment Patients. Journal of Psychoactive Drugs 53:1, pages 55-64.
Read now
Einat Peles, Shaul Schreiber, Anat Sason & Miriam Adelson. (2016) Risk factors for weight gain during methadone maintenance treatment. Substance Abuse 37:4, pages 613-618.
Read now
Debra F. Hobbins. (2010) Case Report: Methadone Maintenance Dose of 1200 mg/day in an Ultra-rapid Metabolizer. Journal of Addictions Nursing 21:1, pages 22-36.
Read now

Articles from other publishers (9)

Milo Meini, Marco Moncini, Laura Daini, Tania Giarratana, Daniela Scaramelli, Silvio Chericoni, Fabio Stefanelli & Paola Rucci. (2015) Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment. European Journal of Pharmacology 760, pages 1-6.
Crossref
Einat Peles, Shaul Schreiber, Shirley Linzy, Yoav Domani & Miriam Adelson. (2015) Differences in Methylphenidate Abuse Rates Among Methadone Maintenance Treatment Patients in Two Clinics. Journal of Substance Abuse Treatment 54, pages 44-49.
Crossref
Branko Naumovski & Robert G. Batey. (2014) High-Dose Methadone Transfer to Buprenorphine in Outpatient Settings. International Journal of Mental Health and Addiction 13:2, pages 194-203.
Crossref
Orna Levran, Einat Peles, Sara Hamon, Matthew Randesi, Miriam Adelson & Mary Jeanne Kreek. (2013) CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction . Addiction Biology 18:4, pages 709-716.
Crossref
Orna LevranEinat Peles, Matthew Randesi, Xu Shu, Jurg Ott, Pei-Hong Shen, Miriam Adelson & Mary Jeanne Kreek. (2013) Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics 14:7, pages 755-768.
Crossref
O Levran, E Peles, S Hamon, M Randesi, C Zhao, B Zhang, M Adelson & M J Kreek. (2011) Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment. The Pharmacogenomics Journal 12:4, pages 319-327.
Crossref
Einat Peles, Shaul Schreiber & Miriam Adelson. (2009) Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose. European Neuropsychopharmacology 19:8, pages 581-588.
Crossref
M.J. Kreek, S.D. Schlussman, B. Reed, Y. Zhang, D.A. Nielsen, O. Levran, Y. Zhou & E.R. Butelman. (2009) Bidirectional translational research: Progress in understanding addictive diseases. Neuropharmacology 56, pages 32-43.
Crossref
Einat Peles, Gershon Bodner, Mary Jeanne Kreek, Vera Rados & Miriam Adelson. (2007) Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients-a cross-sectional study. Addiction 102:2, pages 289-300.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.